Page last updated: 2024-08-21

dehydroepiandrosterone sulfate and troglitazone

dehydroepiandrosterone sulfate has been researched along with troglitazone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunaif, A; Finegood, D; Quintana, B; Scott, D; Whitcomb, R1
Azziz, R; Ehrmann, DA; Fereshetian, AG; Ghazzi, MN; Legro, RS; O'Keefe, M1

Trials

2 trial(s) available for dehydroepiandrosterone sulfate and troglitazone

ArticleYear
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:9

    Topics: Adult; Body Mass Index; Chromans; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Estrone; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Regression Analysis; Testosterone; Thiazoles; Thiazolidinediones; Troglitazone

1996
Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.
    Fertility and sterility, 2003, Volume: 79, Issue:4

    Topics: Adrenal Glands; Adult; Blood Glucose; Chromans; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Prospective Studies; Thiazoles; Thiazolidinediones; Troglitazone

2003